Treatment of Acne Vulgaris With Doryx Tablets Compared to Doxycyline Hyclate

• Status: Completed
• Trial end date: 2008-09-01
• Target enrollment: 0
• Participant gender: All

Summary

Randomized, multi-center, open label, active-comparator study to compare the efficacy and tolerability of Doryx Delayed Release Tablets to doxycycline hyclate in patients with moderate to severe acne vulgaris.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Warner Chilcott
• Treatments: Doxycycline

Criteria

Inclusion Criteria:

• Must be 12 years of age or older.

• Has a diagnosis of facial acne vulgaris with no more than two nodules on the face.

Exclusion Criteria:

• Is allergic to tetracycline-class antibiotics or to any ingredient in the study medication.

• Has a history of pseudomembranous colitis or antibiotic-associated colitis.

• Has a history of hepatitis or liver damage or renal impairment.